BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 20797926)

  • 1. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
    Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
    Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propranolol therapy for periocular and orbital infantile haemangiomas].
    Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
    Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol for infantile haemangioma: striking effect in the first weeks.
    Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
    Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
    Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
    Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile haemangiomas: a challenge in paediatric dermatology.
    Schwartz RA; Sidor MI; Musumeci ML; Lin RL; Micali G
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):631-8. PubMed ID: 20565561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of propranolol in infantile haemangioma among Chinese children.
    Chik KK; Luk CK; Chan HB; Tan HY
    Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature.
    Oksiuta M; Matuszczak E; Debek W; Dzienis-Koronkiewicz E; Hermanowicz A
    J Matern Fetal Neonatal Med; 2016; 29(1):64-8. PubMed ID: 25385271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemangioma and propranolol.
    Engberg Damsgaard T; Vandborg Bjerre J
    J Plast Surg Hand Surg; 2014 Feb; 48(1):86-8. PubMed ID: 23837510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
    Phillips RJ; Penington AJ; Bekhor PS; Crock CM
    J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol-resistant infantile haemangiomas.
    Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
    Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
    Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose propranolol regimen for infantile haemangioma.
    Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
    J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
    Moodley ST; Hudson DA; Adams S; Adams KG
    Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.